期刊文献+

格列卫与多西紫杉醇联合对人乳腺癌细胞株MCF-7及其裸鼠移植瘤的作用 被引量:2

Effect by Gleevec Combines with Docetaxel in Human Breast Cancer MCF-7 Cell and Xenograft in Nude Mice
暂未订购
导出
摘要 目的:探讨分子靶向药物格列卫与多西紫杉醇联合对人乳腺癌细胞株MCF-7的凋亡及其裸鼠皮下移植瘤生长的影响。方法:采用流式细胞检测仪检测MCF-7细胞在格列卫与多西紫杉醇单独处理及共同处理条件下的凋亡率;建立人乳腺癌细胞株MCF-7裸鼠皮下移植瘤模型,观察格列卫与多西紫杉醇单独治疗组及联合治疗组移植瘤的生长,计算抑瘤率。结果:MCF-7细胞在格列卫与多西紫杉醇共同处理条件下的凋亡率(50.86%)远高于多西紫杉醇单独处理(22.06%)及同剂量格列卫组单独处理(8.13%)条件下的凋亡率;高剂量多西紫杉醇与格列卫联合组肿瘤质量与单独多西紫杉醇组比较,差异虽然没有显著性,但联合组抑瘤率高达99.55%,高于多西紫杉醇组(97.43%),q值为1.014;中剂量多西紫杉醇与格列卫联合组肿瘤质量与单独多西紫杉醇组比较,差异有高度显著性,联合组抑瘤率达96.53%,高于多西紫杉醇组(92.01%),q值为1.02;低剂量多西紫杉醇与格列卫联合组肿瘤质量与单独多西紫杉醇组比较,差异有高度显著性,联合组抑瘤率达68.20%,高于多西紫杉醇组(58.40%),q值为1.004。结论:格列卫与凋亡诱导剂多西紫杉醇共同处理MCF-7细胞能达到协同诱导凋亡的效果;高、中、低剂量的多西紫杉醇与格列卫联合对人乳腺癌细胞株MCF-7裸鼠移植瘤增殖的抑制具有相加作用。 Objective: To investigate the effects of Gleevec combined with docetaxel in human breast cancer MCF-7 cell in vitro and in vivo. Methods: MCF-7 cell were treated with Gleevec and/or docetaxel, and cell apoptosis was accessed by SubG1 measured with FACS. Mice xenograft models were established with MCF-7 human breast cancer cells and the mice were treated with Gleevec and docetaxel, the growth rate of xenograft was accessed and the tumor growth inhibition rate was calculated. Results: Cell apoptosis rate induced by the Gleevec combined with docetaxel(50.86%) was higher significantly compared to docetaxel group(22.06%) and Gleevec group(8.13%) at the same dosage. Significant differences in average tumor weight were not found between the high dose of docetaxel and Gleevec combined group and the docetaxel group, but the tumor growth inhibition rate was 99.55% in the combined group that was higher than docetaxel group (97.43%) (q=1.014). Significant differences in average tumor weight were found between the middle dose of docetaxel and Gleevec combined group and the docetaxel group, and the tumor growth inhibition rate was 96.53% in the combined group that was higher than docetaxel group (92.01%)(q=1.02). Significant differences in average tumor weight were found between the low dose of docetaxel and Gleevec combined group and the docetaxel group, and the tumor growth inhibition rate was 68.20% in the combined group that was significantly higher than docetaxel group (58.40%)(q=1.004). Conclusion: Gleevec and docetaxel showed significant synergy effect in inducing MCF-7 tumor cell apoptosis. Add effect was observed when docetaxel was administered with Gleevec in the treatment of tumor xenograft in nude mice.
出处 《生物技术通讯》 CAS 2009年第5期662-665,共4页 Letters in Biotechnology
关键词 格列卫 多西紫杉醇 凋亡 裸鼠 乳腺癌 Gleevec docetaxel apoptosis nude mice breast cancer
  • 相关文献

参考文献8

  • 1Gligorov J,Lotz J P.Preclinical pharmacology of the taxanes:implications of the differences[J].Oncologist,2004,9(Suppl 2):3-8.
  • 2Druker J B,Tamurs S,Buchdunger E,et al.Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells[J].Nat Med,1996,2(5):561-566.
  • 3Deininger M W,Goldman J M,Lydon N,et al.The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCRABL-positive cells[J].Blood,1997,90,3691-3698.
  • 4Gambacoti-Passerini C,le Coutre P,Mologni L,et al.Inhibiter of the ABL kinase activity blocks the proliferation of BCR/ABL leukemic cells and induces apoptosis[J].Blood Cells Mol Dis,1997,23:380-394.
  • 5Druker H J,Lydon N B.Lessons learned from the development of an tyrosine Kinase inhibiter for chronic myelegenous ieukemia[J].J Clin Invest,2000,105(1):37.
  • 6Margaret E M,Caroline D R,Mark W K,et al.Marked regression of metastatic pilocytic astrocytoma during treatment with lmatinib Mesylate(STI571)[J].Pediatr Hematol Oncol,2003,25(8):644-648.
  • 7Jemal A,Murray T,Samuels A,et al.Cancer stautistics 2003[J].CA Cancer J Clin,2003,53(1):5-26.
  • 8Giordano A,Rustum Y M,Wenner C E.Cell cycle molecular targets for diagnosis and therapy; tumor suppressor genes and cell cycle progression in cancer[J].J Cell Biochem,1998,70(1):1-7.

同被引文献30

  • 1刘秀峰,秦叔逵,王琳,钱军,陈映霞,何泽明,龚新雷,杨柳青.恩度与化疗联合治疗多种晚期恶性肿瘤的临床观察[J].临床肿瘤学杂志,2007,12(4):241-245. 被引量:144
  • 2武国海,周彩红,王明伟.前列腺癌治疗药物的研究新进展[J].中国新药杂志,2007,16(17):1330-1336. 被引量:4
  • 3PEYROMAURE M, DEBRE B, MAO K, et al. Management of prostate cancer in China: a multicenter report of 6 institu tions[J]. Journal of Urology, 2005,174(5):1794- 1797.
  • 4FOLKMAN J, WATSON K, INGBER D, et al. Induction of angiogenesis during the transition from hyperplasia to neoplasia[J]. Nature, 1989,339(6219):58-61.
  • 5YAMANAKA K, ROCCHI P, MIYAKE H, et al. A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensi- tivity in androgen-independent human prostate cancer PC3 cells[J]. Molecular Cancer Therapeutics, 2005,4 (11) : 1689- 1698.
  • 6SHI Y, CHATTERJEE S J, BRANDS F H, et al. Role of co- ordinated molecular alterations in the development of andro- gen-independent prostate cancer: an in vitro model that cor- roborates clinical observations[J]. BJU International, 2006, 97(1):170 -178.
  • 7LEE J T, STEELMAN L S, MCCUBREY J A. Phosphati- dylinositol 3'-kinase activation leads to multidrug resistance protein-1 expression and subsequent chemoresistance in ad- vanced prostate cancer cells[J]. Cancer Research, 2004,64 (22) : 8397-8404.
  • 8胡广原,邹燕梅,赵荆,熊华,张路.重组人血管内皮抑制素联合化疗治疗多种晚期恶性肿瘤[J].临床肿瘤学杂志,2009,14(3):256-258. 被引量:14
  • 9李荔霞,郑积华,张为民.重组人血管内皮抑制素临床应用进展[J].癌症进展,2009,7(2):175-178. 被引量:8
  • 10张业玲,于洪升,刘希光.照射时间延长对小鼠Lewis肺癌MMP-9和E-cad表达影响[J].齐鲁医学杂志,2010,25(2):117-119. 被引量:1

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部